Hetty Carraway, MD, and Eytan Stein, MD, discuss the frontline treatment options for patients with AML and how to select the best treatment approach based on patient and disease factors.
EP. 8: Treatment of Patients Unfit for Intensive Induction with Venetoclax + AzacitidineAugust 11th 2022
Hetty Carraway, MD, highlights the role of venetoclax + azacitidine in the treatment of patients with acute myeloid leukemia who are unfit for intensive induction therapy.
EP. 10: Management of Cytopenia in Patients on Venetoclax + Azacitidine TherapyAugust 18th 2022
Hetty Carraway, MD and Eytan Stein, MD, discuss the appropriate strategies for the management of cytopenias in patients with AML on venetoclax + azacitidine treatment.